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Abstract:  
The novel limonoid, methyl uguenesonate, novel azole, uguenenazole, and novel amide, 
uguenenonamide, together with the known furoquinoline alkaloids flindersiamine and 
maculosidine, and syringaldehyde have been isolated from the root of the East African 
Rutaceae Vepris uguenensis.  While methyl uguenesonate and the furoquinoline alkaloids 
displayed mild antimalarial activity, the azole and amide were completely inactive. 
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Introduction 
The genus Vepris Comm. ex A. Juss. comprises some 80 species of shrubs and trees, 
occurring primarily in tropical Africa, Zanzibar, Madagascar and the Mascarene Islands, and 
to a lesser extent in tropical Arabia and southwest India (Chaturvedula et al., 2003).   
 
Ethnomedicinally, species of the genus Vepris are employed in the treatment of a diverse 
range of ailments, including pneumonia, lung diseases and kidney disorders (Hedberg et al., 
1983), eye troubles, cardiac pains, coughs, colds and influenza (Chhabra et al., 1991; Gurib-
Fakim et al., 1993), headache (Arnold and Gulumian, 1984), menorrhegia and infertility 
(Steenkamp, 2003), and as an aphrodisiac (Poitou et al., 1995), diuretic and antipyretic 
(Gomes et al., 1994), astringent and fortifier (Vera et al., 1990), tonic for angina and 
rheumatism (Gurib-Fakim et al., 1993), and both orally and externally as a treatment for 
malaria (Gessler et al., 1994, 1995).  Vepris uguenensis Engl., the subject of the present 
study, is known is “chemchir” by the Pokot tribe of Kenya, who use it as an antimalarial 
(Cheplogoi, pers. comm.). 
 
Fifteen Vepris species have previously been investigated: V. ampody H.Perr. (Kan-Fan et al., 
1970), V. bilocularis (Wight et Arn.) Engl. (Govindachari and Sundararajan, 1961; 
Govindachari, et al., 1964; Ganguly et al., 1966; Brader et al., 1996), V. dainellii (Pic. Serm.) 
Kokwaro (Dagne et al., 1988), V. elliotii (Radlk.) I. Verd. (Poitou et al., 1995), V. fitoravina 
H.Perr. (Koffi et al., 1987), V. glomerata (F.Hoff.) Engl. (Dagne et al., 1988), V. heterophylla 
R. Let. (Gomes et al., 1983, 1994; Moulis et al., 1994; Sidibe et al., 2001), V. leandriana 
H.Perr. (Rakotondraibe et al.,2001), V. louisii (Ayafor et al., 1980, 1981, 1982a, 1982b, 
1982c; Ngadjui et al., 1982), V. macrophylla (Baker) I. Verd. (Koffi et al., 1987), V. 
madagascarica (Baill.) H.Perr. (Billet and Favre-Bonvin, 1973), V. pilosa (Baker) I. Verd. 
(Haensel and Cybulski, 1978), V. punctata (I.Verd.) W. Mziray (Chaturvedula et al., 2003), 
V. sclerophylla H.Perr. (Rasoanaivo et al., 1999) and V. stolzii I.Verd. (Khalid and 
Waterman, 1982).  Although furoquinoline alkaloids are the most common isolates, acridone 
and quinol-2-one alkaloids, limonoids and triterpenoids have also been found (Dictionary of 
Natural Products, 2007).  
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Results and Discussion  
A novel limonoid derivative, methyl uguenesonate (1), a novel azole, uguenenzole (2), a 
novel amide, uguenenonamide (3) (Figure 1), the known furoquinoline alkaloids 
flindersiamine (4) and maculosidine (5), and syringaldehyde (6), were isolated from the 
dichloromethane extract of the roots of Vepris uguenensis. 
 
The HREIMS of methyl uguenesonate (1) showed a molecular ion peak at m/z 502.2203, 
corresponding to the molecular formula C27H34O9 and indicating 11 double bond equivalents.  
Analysis of the 2D NMR spectra, and comparison with literature values (Ng et al., 1987; 
Patra et al., 1988) for limonin showed that (1) also possessed the furan ring (H 7.39 (1H, s), 
H-21; H 6.30 (1H, s), H-22; H 7.37 (1H, s), H-23; C 141.1, 109.8, 143.1 (each CH), C-21, 
C-22, C-23; C 120.3, C, C-20), 14,15-epoxy ring D lactone (H 5.57 (1H, s), H-17; H 
3.91 (1H, s), H-15; C 78.1 (CH), C-17; C 167.5 (C), C-16; C 55.4 (CH), C-15; C 69.5 (C), 
C-14), C-7 ketone (C 211.8 (C)), contracted ring A (H 4.15 (1H, m), H-3; C 74.7 (CH), C-
3; C 83.8 (C), C-4), and four quaternary methyl groups (H 1.17, 1.10, 1.24, 1.39 (each 3H, 
s), 3H-18, 3H-28, 3H-29, 3H-30; C 19.6, 24.2, 28.9, 16.9 (each CH3), C-18, C-28, C-29, C-
30) of the limonin skeleton.  However, although the signals of the C-19 oxymethylene (C 
68.7 (CH2)) and ester carbonyl (C 173.6 (C)) carbons were still present in (1), they differed 
from the literature values; additionally, while (1), relative to limonin, lacked a double bond 
equivalent, it possessed both an additional carbon and additional oxygen atom, which 
appeared as the signals of a carbomethoxy group (H 3.72 (3H, s); C 52.3 (CH3)).  Methyl 
uguenesonate, with structure (1) in Figure 1 below, is thus a novel derivative of limonin in 
which the ring A’ lactone has undergone cleavage to give the hydroxy-acid, followed by 
methyl esterification. 
 
The HREIMS of uguenenazole (2) showed a molecular ion peak at m/z 251.0948, 
corresponding to the molecular formula C16H13NO2 and 11 double bond equivalents.  
Inspection of the 1H, 13C and 2D NMR spectra showed (2) to possess two aromatic rings, one 
monosubstituted (H 8.08 (2H, dd, J = 8.1, 1.7 Hz), H-2’/6’; H 7.46 (2H, m), H-3’/5’); H 
7.44 (1H, m), H-4’)) and the second p-methoxy disubstituted (H 7.64 (2H, d, J = 9.0 Hz), H-
2”/6”; H 6.96 (2H, d, J = 9.0 Hz), H-3”/5”); H 3.84 (3H, s)).  The remaining C3HNO and 3 
double bond equivalents were accounted for as a 2,5-disubstituted-1,3-oxazole ring, with a 
correlation in the NOESY spectrum between the signals of H-4 and H-2”/6” placing the p-
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methoxy disubstituted ring at C-5.  Uguenenazole, as the novel 5-(4”-dimethoxyphenyl)-2-
phenyl-1,3-oxazole) has structure (2) in Figure 1 below. 
 
Balsoxine (5-(3,4-dimethoxyphenyl)-2-phenyl-1,3-oxazole), from Amyris balsamifera L. 
((Burke et al., 1979), and its 3,4-methylenedioxy analogue texamine, from A. texana P. 
Wilson (Dominguez et al., 1988), are the only compounds with the 2,5-diphenyl-1,3-oxazole 
ring skeleton to have been isolated to date from natural sources.  Even 2,5-diaryl-1,3-oxazole 
compounds are uncommon, with a further 14 examples only reported in the literature.  Apart 
from phorbazoles A-D, four chlorinated-2-pyrrole derivatives from a Phorbas species of 
marine sponge (Rudi et al., 1994), all of the others have come from species of the Rutaceae 
(Dictionary of Natural Products, 2007). 
 
The HREIMS of uguenenonamide (3) showed a molecular ion peak at m/z 269.1045, 
corresponding to the molecular formula C16H15NO3 and 10 double bond equivalents.  Like 
(2), (3) also has two aromatic rings, one monosubstituted (H 7.86 (2H, dd, J = 7.5, 1.7 Hz), 
H-2/6; H 7.45 (2H, dd, J = 7.5, 7.5 Hz), H-3/5); H 7.51 (1H, m), H-4)) and the second p-
methoxy disubstituted (H 8.00 (2H, d, J = 8.0 Hz), H-2’/6’; H 6.97 (2H, d, J = 8.0 Hz), H-
3’/5’); H 3.90 (3H, s)).  Also visible in the spectra of this compound were the signals of an 
amide carbonyl group (H 7.32 (1H, br s), 3364 cm-1, N-H; C 167.4 (C)), a ketone carbonyl 
group (C 192.6 (C)), and an isolated methylene carbon (H 4.89 (2H, s); C 46.5 (CH2)).  The 
downfield position of the signals of both H-2/6 and H-2’/6’ suggested that both aromatic 
rings had a benzylic carbonyl group, while correlations in the NOESY spectrum between the 
1H resonances of the methylene protons and H-2’/6’ on one hand, and between those of the 
amide proton and H-2/6 on the other, confirmed the structure as that of (3) in Figure 1. 
 
Surprisingly, the N-benzoylbenzamide skeleton that characterizes uguenenonamide (3) has 
been reported only once previously, in the form of muricatisine from Oxytropis muricata 
(Pall.) DC. and O. puberula Boriss (Demeuov et al., 1999), two Asian members of the 
Fabaceae.  This is the first report of both an azole such as (2) and its amide (3) precursor 
simultaneously being found, which is surprising as construction of the azole ring by 
Robinson-Gabriel dehydration of 2-acylaminoketones is a standard laboratory procedure (cf. 
eg. Brain and Paul, 1999; Nicolaou et al., 2004). 
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The known compounds were identified as flindersiamine (4) (Chaturvedula et al., 2003), 
maculosidine (5) (Sekiba, 1973), and syringaldehyde (6) (Moodley, 2001) by comparison of 
their physical properties and spectral data with literature values. 
 
As species of the Rutaceae (Watt and Breyer-Brandwijk 1962; Kokwaro 1976; Neuwinger 
2000) and Meliaceae (MacKinnon et al., 1997) are frequently cited as antimalarials or 
febrifuges in African traditional medicine, and the antiplasmodial activity of a variety of both 
limonoids (Khalid et al., 1986; MacKinnon et al., 1997) and furoquinoline alkaloids (Basco et 
al., 1994) has previously been demonstrated, all six compounds were tested against the 3D7 
(chloroquine susceptible, CQS) and FCM29 (chloroquine resistant, CQR) strains of P. 
falciparum.  While compounds (2-4) were found to be completely inactive against both 
strains, (1), (5) and (6) displayed mild activity, with IC50 values of 10.4 ± 4.4, 29.2 ± 3.2, and 
13.0 ± 11.5 µg.mL-1, and 13.8 ± 1.0, 40.4 ± 3.6, and 21.4 ± 8.2 µg.mL-1, against the CQS and 
CQR strains, respectively.  No statistically significant difference between the activity against 
CQS and CQR strains was observed, except that of maculosidine (5), which was more active 
against the CQS 3D7 strain. 
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Experimental 
3.1 General 
Melting points were determined on a Kofler micro-hot stage melting point apparatus and are 
uncorrected. NMR spectra were recorded at room temperature on a 400MHz Varian UNITY-
INOVA spectrometer. 1H NMR spectra were referenced against the CHCl3 signal at H 7.27, 
and 13C NMR spectra against the corresponding signal at C 77.0. Coupling constants are 
given in Hz.  Optical rotations were measured at room temperature in chloroform using a 
Perkin-Elmer 241 polarimeter with a 10 cm flow tube.  IR spectra were recorded on a Nicolet 
Impact 400D Fourier-Transform Infrared (FT-IR) spectrometer, using NaCl windows with 
CHCl3 as solvent against an air background. UV spectra were obtained on a Varian DMS 300 
UV–visible spectrometer.  HREIMS were taken on a Micromass VG 70 SEQ instrument. 
 
3.2 Plant material 
The roots of Vepris uguenensis (157 g) were collected in the Barwessa Division, Baringo 
District, Kenya in July 2004.  The plant was identified by Mr Ezekiel Cheboi of the 
Department of Natural Resources, Egerton University, Kenya.  A voucher specimen (PKC 
02, NH) has been retained at the Natal Herbarium, Durban. 
 
3.3 Extraction and isolation of compounds 
Air-dried, ground roots were left to stand in CH2Cl2 at room temperature for 5 days. The 
extract was decanted and concentrated to yield a crude extract (8.20 g) which was separated 
using column chromatography over silica gel (Merck 9385) with a hexane/EtOAc step 
gradient (100:0 to 50:50).  Further purification using the given solvent systems yielded the 
following; hexane/EtOAc (75:25) yielded methyl uguenesonate (1) (13.9 mg), CH2Cl2/EtOAc 
(95/5) yielded uguenenzole (2) (15.9 mg), CH2Cl2 (100) yielded uguenenonamide (3) (3.6 
mg) and maculosidine (5) (5.9 mg), hexane/EtOAc (85/15) yielded flindersiamine (4) (41.7 
mg), and CH2Cl2/MeOH (99/1) yielded syringaldehyde (6) (5.2 mg).  
 
 
3.3.1 methyl uguenesonate (1): white crystals; m.p. 118-119 0C; max (NaCl) cm-1 3405, 
2927, 1737, 1702, 1436, 1366, 1271, 1106, 1030; HREIMS (70 eV) 502.2206 (calc. for 
C27H34O9 502.2203); EIMS (70 eV): m/z (rel. int.): 502 [M+], 487 (2), 471 (2), 445 (9), 379 
(100), 361 (6), 321 (4), 259 (13), 201 (10), 161 (6), 103 (17), 95 (11), 43 (18); [α]D25 +82.3 (c 
= 0.13, CHCl3); 1H NMR spectral data (400MHz, CDCl3) H 7.39 (1H, s, H-21), 7.37 (1H, s, 
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H-23), 6.30 (1H, s, H-22), 5.57 (1H, s, H-17), 4.15 (1H, m, H-3), 3.99 (1H, m, H-19b), 3.91 
(1H, s, H-15), 3.73 (1H, m, H-19a), 3.72 (3H, s, CO2CH3), 2.97 (1H, br s, H-9), 2.61 (1H, m, 
H-2b), 2.57 (1H, m H-6), 2.50 (1H, m, H-2a), 2.45 (1H, m, H-6), 2.28 (1H, m, H-11), 
2.18 (1H, m, H-5), 1.75 (1H, m, H-12), 1.70 (1H, m, H-11), 1.50 (1H, m, H-12), 1.39 
(3H, s, 3H-30), 1.24 (3H, s, 3H-29), 1.17 (3H, s, 3H-18), 1.10 (3H, s, 3H-28); 
13
C NMR 
spectral data (100MHz, CDCl3) C 211.8 (C, C-7), 173.6 (C, C-1), 167.5 (C, C-16), 143.1 
(CH, C-23), 141.1 (CH, C-21), 120.3 (C, C-20), 109.8 (CH, C-22), 83.8 (C, C-4), 78.1 (CH, 
C-17), 74.7 (CH, C-3), 69.5 (C, C-14), 68.7 (CH2, C-19), 55.4 (CH, C-15), 52.3 (CH3, 
CO2CH3), 48.3 (C, C-8), 39.5 (CH2, C-6), 39.3 (C-13), 36.9 (CH2, C-2), 35.6 (CH, C-9), 28.9 
(CH3, C-29), 27.8 (CH2, C-12), 24.2 (CH3, C-28), 19.6 (CH3, C-18), 18.5 (CH2, C-11), 16.9 
(CH3, C-30). 
 
3.3.2 uguenenazole (2): white crystals; m.p. 133-135 0C; (NaCl) cm-1 3334, 2927, 2857, 
1690, 1607, 1507, 1466, 1260, 1177, 1030; HREIMS: 251.0948 (calc. for C16H13O2N 
251.0946); EIMS: m/z (rel. int.): 251 [M+], 236 (17), 220 (28), 214 (8), 208 (5), 196 (7), 181 
(6), 153 (11), 152 (100), 149 (9), 136 (8), 135 (87), 132 (8), 129 (4), 125 (4), 122 (3), 121 
(30), 111 (4), 109 (4), 107 (9), 106 (5), 105 (51), 92 (13), 89 (4), 83 (4), 81 (6), 78(7), 77 
(59), 76 (6), 75 (4), 74 (5), 71 (5), 69 (4), 65 (6), 64 (9), 63 (11), 57 (9), 55 (7), 51 (20), 50 
(8), 43 (8), 41 (6), 40 (8); UV λmax (CHCl3) nm (log ε) 315 (4.51); 1H NMR spectral data 
(400MHz, CDCl3) H 8.08 (2H, dd, J = 8.1, 1.7 Hz, H-2’/6’), 7.64 (2H, d, J = 9.0 Hz, H-
2”/6”), H 7.46 (2H, m, H-3’/5’), 7.44 (1H, m, H-4’), 7.30 (1H, s, H-4), 6.96 (2H, d, J = 9.0 
Hz, H-3”/5”), H 3.84 (3H, s, -OCH3); 13C NMR spectral data (100MHz, CDCl3) 160.6 (C, C-
2), 159.8 (C, C-4”), 151.3 (C, C-5), 130.1 (CH, C-4’), 128.8 (CH, C-3’/5’), 127.6 (C, C-1’), 
126.1 (CH, C-2’/6’), 125.7 (CH, C-2”/6”), 121.9 (CH, C-4), 120.9 (C, C-1”), 114.4 (CH, C-
3”/5”), 55.4 (CH3, -OCH3) 
3.3.3 uguenenonamide (3): white crystals; m.p. 106-108 0C; max (NaCl) cm-1: 3364, 2927, 
2857, 1684, 1631, 1602, 1578, 1525, 1436, 1248, 1030; HREIMS: 269.1045 (calc. for 
C16H15O3N 269.1051); EIMS: m/z (rel. int.): 269 [M+], 258 (8), 182 (5), 149 (6), 136 (9), 135 
(100), 107 (3), 105 (14), 92 (5), 77 (17), 57 (4), 51 (4), 43 (4), 41 (3); UV λmax  (CHCl3) nm 
(log ε) 290 (4.53); 1H NMR spectral data (400MHz, CDCl3) H 8.00 (2H, d, J = 8.0, H-2’/6’), 
7.86 (2H, dd, J = 7.5, 1.7 Hz, H-2/6), 7.51 (1H, m, H-4), 7.45 (2H, dd, J = 7.5, 7.5 Hz, H-
3/5), 7.32 (1H, br s, N-H), 6.97 (2H, d, J = 8.0 Hz, H-3’/5’), 4.89 (2H, s, 2H-9), 3.90 (3H, s, -
OCH3),  
13
C NMR spectral data (100MHz, CDCl3) 192.6 (C, C-10), 167.4 (C, C-7), 164.4 (C, 
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C-4’), 134.0 (C, C-1), 131.7 (CH, C-4), 130.3 (CH, C-2’/6’), 128.6 (CH, C-3/5), 127.3 (C, C-
1’), 127.1 (CH, C-2/6), 114.2 (CH, C-3’/5’), 55.6 (CH3, -OCH3), 46.5 (CH2, C-9). 
 
3.4 In vitro antimalarial testing 
The chloroquine-sensitive 3D7 and chloroquine-resistant FCM29 strains of Plasmodium 
falciparum were maintained in continuous culture (Trager and Jensen, 1976) and used to 
assess the antiplasmodial activity of compounds isolated from V. uguenensis. The in vitro 
antiplasmodial testing was performed by use of the isotopic method as described elsewhere 
(Desjardins et al., 1979, Rason et al., 2007). Samples were tested in 96-well plates in 
triplicate at final concentrations of 64, 16, 8, 4, 2, and 0.5µg/mL. We considered as inactive 
molecules with IC50 values >64 µg/ml. Student’s t test was used for statistical comparison 
between mean IC50s. Difference was significant for P values under 0.05.  
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Figure 1: Isolates from Vepris uguenensis
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